PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of oncotargetLink to Publisher's site
 
Oncotarget. 2017 August 22; 8(34): 56932–56941.
Published online 2017 June 6. doi:  10.18632/oncotarget.18378
PMCID: PMC5593614

Relationship between the TERT, TNIP1 and OBFC1 genetic polymorphisms and susceptibility to colorectal cancer in Chinese Han population

Abstract

Colorectal cancer (CRC) is one of the most common diseases worldwide, and telomere length has been reported correlate with CRC. This study aimed to investigate whether polymorphisms of telomere length related genes are associated with susceptibility to CRC in Chinese Han population. 11 SNPs from TERT, TNIP1 and OBFC1 genes were selected and genotyped, in addition odds ratio (OR) and 95% confidence intervals (CI) were used to evaluate association between the SNPs and CRC risk in 247 patients clinically and 300 controls in a Chinese Han population. Our results showed that minor allele “G” of rs7708392 and minor allele “C” of rs10036748 in TNIP1 gene were significantly associated with an increased the CRC risk in genotype model, dominant model and additive model after Bonferroni's multiple adjusted (P<0.0011). Moreover, the two SNPs rs7708392 and rs10036748 were in strong linkage disequilibrium. We observed that the haplotype “G-C” was more frequent among CRC patients and associated with a 1.58-fold increased CRC risk (95%CI=1.17-2.13, P=0.003). Contrarily, haplotype “C-T” was associated with a 0.63-fold reduced CRC risk (95%CI=0.47-0.86, P=0.003). Additionally, SNPs in this study except rs7708392 and rs10036748 were found a modest connection with CRC risk. In conclusion, our study firstly provides evidence for a novel association between polymorphisms of telomere length related TNIP1 gene and CRC susceptibility in Chinese Han population, and the results need a further identification in a large sample size and other populations.

Keywords: colorectal cancer, polymorphism, TERT, TNIP1, OBFC1

INTRODUCTION

Colorectal cancer (CRC) is the third most common type of cancer and also the fourth common cause of cancer death worldwide [1]. In the United States, 160, 000 cases of CRC are diagnosed, and 57, 000 patients die per year because of CRC, making it the second leading cause of death from cancer [2]. CRC incidence and mortality undoubtedly increase the national economic burden. Thus, it is essential to uncover the molecular basis of individual susceptibility to CRC, and to confirm the initiate factors of tumor development, progression and responsiveness.

The etiology of CRC results from interactions of many factors, which were not fully understood. Study have revealed that progression accumulation of genetic and epigenetic alterations can lead to the malignant transformation of normal colonic epithelium, and genomic stability seems to be an crucial molecular in the early stage of cancer [3]. Approximately 85% of CRC are defined as chromosomal instability which is mainly driven by the telomere dysfunction [4]. Telomere is a structure that can protect chromosomes from end-to-end fusion and DNA degradation. Telomere is maintained by telomerase, a ribonucleoprotein complex containing an internal RNA component and a catalytic protein which encoded by TERT gene with reverse transcriptase activity. Moreover, evidence has reported that the telomere length have the strongest association with many cancer, such as bladder, esophageal, gastric and renal cancers in a meta-analysis [5]. TERT, TNIP1 and OBFC1 genes have been reported associated with telomere length in genome wide association studies (GWAS) [6, 7].

Furthermore, a variety of studies have also suggested that the polymorphisms of telomere length related genes associated with the development of cancer. For example, variants of rs10069690 and rs2242652 in TERT has been identified increase the risk of breast cancer [8], and another research reported that polymorphism of rs2242652 have an association with the risk of melanoma in Caucasians [9]. More and more clinical researches have focused on the association between single nucleotide polymorphism (SNP) and the disease risk, and heredity variant has been confirmed to be the primarily factor in the progression of CRC. Formerly, some articles had revealed that the mutations in the genes NRAS, PI3K, BRAF, CASC8, SMAD7, DNMT1 and XRCC3 decreases or increases risk of colorectal cancer [1012]. In addition, study found telomere length of non-tumor tissues had a significant longer than the telomere length of CRC tissues [13]. However, only a few studies have focused on the polymorphisms of telomere length-related genes on susceptibility to CRC in the Han Chinese population. Thus, here we performed a case-control study to investigate the association between polymorphisms of the 11 SNPs in TERT, TNIP1 and OBFC1 and the risk of CRC in Chinese Han population.

RESULTS

Characteristic of the study participants CRC

The demographic characteristic of the study population, including gender and age are summarized in Table Table1.1. The study included 247 CRC cases (140 females, 107 males) and 300 controls (120 females, 180 males). The ages of cases and controls were 58.32±12.75 years and 60.42±5.14 years, respectively. After statistical analysis, there were significant differences between these groups in gender (P<0.001) and age (P=0.015). Therefore, unconditional logistic regression analysis adjustment for gender and age was used to our subsequent data.

Table 1
Characteristic of the control individuals and patients with colorectal cancer

Genotype model analysis

The basic information related to 11 SNPs in our study such as chromosomal position, allele, minor frequency (MAF), and HWE test results, appear in Table Table2.2. We assumed that minor allele of each SNPs was a risk allele compared to wild type allele. All the SNPs were in HWE in the control groups (P>0.05). We then compared the differences in frequency distributions of alleles between cases and controls using Pearson Chi-Square test except rs9420907, whose frequency distributions was calculated by Continuity Correction test. The result showed that the risk allele frequency of “G” of rs7708392 was higher in cases, and it was associated with a 1.518-flod increased the CRC risk at a 5% level (OR=1.52, 95%CI=1.15-2, P=0.003). And, the risk allele “C” of rs10036748 also increased the risk of CRC (OR=1.52, 95%CI=1.15-2, P=0.003). Risk allele frequencies of the other SNPs were not had a significant difference between cases and controls.

Table 2
Allele frequencies of candidate SNPs among the cases and controls and odds ratio estimates for colorectal cancer

We further assessed the association between prominent polymorphism loci and CRC risk under four models (genotype, dominant, recessive, and additive model) using unconditional logistic regression analysis adjustment for gender and age in Table Table3.3. The results showed that rs10069690 had a modest association with CRC risk in genotype model (C/T vs C/C OR=1.49, 95%CI=1-2.22, P=0.049). And an extremely significant association was found between rs7708392 and CRC risk in genotype model (C/G vs C/C OR=1.86, 95%CI=1.3-2.66, P=0.0007), dominant model (C/G-G/G vs C/C OR=1.82 95%CI=1.28-2.58, P=0.0008), and additive model (OR=1.58, 95%CI=1.17-2.13, P=0.003). At the same time, rs10036748 was also associated with increased the CRC risk in genotype model (T/C vs T/T OR=1.86, 95%CI=1.3-2.66, P=0.0007), dominant model (T/C-C/C vs T/T OR=1.82, 95%CI=1.28-2.58, P=0.0008) and additive model (OR=1.58 95%CI=1.17-2.13, P=0.003). In addition, rs12765878 and rs11191865 might be a protective role in CRC risk under genotype model (T/C vs T/T OR=0.69, 95%CI=0.48-1, P=0.048; G/A vs G/G OR=0.68, 95%CI=0.48-0.98, P=0.041 respectively). After Bonferroni's multiple adjustment applied to our date, we were pleasantly surprised to find that rs7708392 and rs10036748 were still significantly associated with CRC risk. The associations of other SNPs were disappeared.

Table 3
Genotype distributions of prominent SNPs under model and their association with the risk of developing colorectal cancer

Haplotype analysis

Lastly, we performed haplotype analysis for the TERT, TNIP1 and OBFC1 genes and found 3 strong linkage of these candidate SNPs, containing rs10069690-rs2242652 block in TERT (Figure (Figure1),1), rs7708392-rs10039748 block in TNIP1 (Figure (Figure2),2), and rs3814220-rs12765878-rs11191865 block in OBFC1 (Figure (Figure3).3). The associations between haplotypes of the 3 blocks and the CRC risk are listed in Table Table4.4. We found that “C-A” haplotype frequency of rs10069690-rs2242652 block was statistically significant difference between cases and controls (0.002 vs 0.017, P=0.016), but this haplotype was not significantly reduced the CRC risk (OR=0.14, 95%CI=0.02-1.15, P=0.068). Furthermore, two haplotypes of rs7708392-rs10039748 block were found extremely significant associated with CRC risk, “G-C” haplotype with an increased the CRC risk (OR=1.58, 95%CI=1.17-2.13, P=0.003), the other “C-T” haplotype with a decreased the CRC risk (OR=0.63, 95%CI=0.47-0.86, P=0.003). No significant association was found in rs3814220-rs12765878-rs11191865 block.

Figure 1
Haplotype block map for part of the SNPs in the TERT gene
Figure 2
Haplotype block map for part of the SNPs in the TNIP1 gene
Figure 3
Haplotype block map for part of the SNPs in the OBFC1 gene
Table 4
Haplotype frequencies and the association with colorectal cancer risk in case and control subjects

DISCUSSION AND CONCLUSION

The present research examined 11 allelic variants within the telomere length-related TERT, TNIP1 and OBFC1 genes and their implication on CRC risk in Chinese Han population. Overall, the results demonstrated that polymorphisms of rs7708392 and rs10039748 in TNIP1 had a significant influence on CRC susceptibility for the first time. Moreover, these two SNPs exhibited increase the CRC risk in genotype model, dominant model and additive model after Bonferroni's correction. Under haplotype analysis, we not only found that the haplotype “G/C” of TNIP1 was associated with a 1.58-fold enhancive the CRC risk, but also found haplotype “CT” significantly decreased the CRC risk by 0.63-fold. These finds indicated that the polymorphism of TNIP1 gene was significantly correlated with the risk of CRC in Chinese Han population, and TNIP1 may play a key role in CRC progression through aberrantly activate the NF-κβ-induced signaling.

TNIP1, located in 5p33.1, encodes an A20-binding protein which can regulate the activation of nuclear factor kappa-β (NF-κβ) [14]. NF-κβ is a transcriptional factor often implicated in a variety of different diseases [15], and article has indicated a critical link between cancers and NF-κβ which plays a crucial role in oncogenesis and the metastasis of tumors through a variety of different ways [16]. Furthermore evidence revealed that NF-κβ is constitutively activated in human colorectal carcinoma tissue [17] and play a key role in colorectal carcinoma progression through activation of its downstream target genes [18]. For example, the decreased expression of NF-κβ could inhibit cell cycle progression in CRC cell lines, and arrest in the G0/G1 phase through down-regulation of its target genes E2F1 and TS [19]. In addition, both reactive oxygen species and inflammation reaction also contribute to the connection between NF-κβ and CRC [20, 21]. Some studies have suggested that the polymorphism of NF-κβ1 and NF-κβ appeared to jointly contribute to CRC risk in the southern Chinese population [22], and the polymorphism of NF-κβ was related to susceptibility and prognosis of CRC patients [23].

However, studies about the association between TNIP1 and colorectal cancer are rarely. Interestingly, many researchers are interested in finding the polymorphism of TNIP1 associated with systemic lupus erythematosus (SLE). Research reported that the risk allele “G” of rs7708392 in TNIP1 has a higher frequency in Asian than in Caucasian, and rs7708392 is a shared SLE susceptibility SNP in the Asian and Caucasian populations [24, 25]. Similarly, rs10039748 within intron 1 of TNIP1 also showed significant association with the susceptibility of SLE, systemic sclerosis [26] and asthma [27]. In this study, a novel association between TNIP1 polymorphisms and CRC risk was found, and this link might emerge through the effect of TNIP1 gene on transcriptional regulation of NF-κβ. We hypothesized that the variant of rs7708392 and rs10039748 might alter the function of A20-binding protein, and thus affect the NF-κβ-induced signal pathway to increase the tumor promotion and maintenance. In the future, the mechanism of TNIP1 polymorphisms in the pathogenesis of CRC need to be further elucidated.

TERT gene is mapped on chromosome 5p15.33, a genomic region which was confirmed to be associated with multiple cancer types. In this current study, we studied the effect of four SNPs from TERT gene on CRC risk in Chinese Han population and found that none of the investigated SNPs were associated with CRC risk. Similar to our results, the risk allele “T” of rs2853676 has been identified not associated with CRC risk in a previous involving an Austrian population [28]. A meta-analysis, rs2853676 in TERT have been identified as being associated with glioma, lung and ovarian cancer, but not melanoma, breast, pancreatic and colorectal cancer [29]. In addition, rs10069690, rs2242652 and rs2853676 were also confirmed not associated with colon and rectal cancer, however, after interacted with body mass index, rs10069690 and rs2242652 showed a significant association with risk of colon cancer in the California population [30]. Our data also did not confirm the correlation between the variant of these four SNPs in TERT and CRC risk in Chinese Han population.

Except the two genes TNIP1 and TERT, we also selected four SNPs from OBFC1 gene, which is located in 10q24.33. Polymorphisms of rs3814220, rs12765878 and rs9420907 have been identified associate with leukocyte telomere length in a meta-analysis [7]. In addition, susceptibility loci rs11191865 was a share risk loci for idiopathic interstitial pneumonia and systemic sclerosis [31]. However, in this case control study, the four SNPs in OBFC1 don't have a correlation with CRC risk in Chinese Han population. Despite the current study possessing the energy, the negative results of major SNPs in this study may convert into positive ones when the sample size of CRC samples is large enough.

In conclusion, our present study firstly provides evidence that rs7708392 and rs10039748 in the TNIP1 gene are associated with the risk of CRC in Chinese Han population. It is possible that TNIP1 might be a new precursory biomarker to CRC and increase the possibility of developing CRC. Our result can provide a theoretical foundation for other researchers to further study the correlation between TNIP1 and susceptibility to CRC in Chinese Han population or other populations.

MATERIALS AND METHODS

Study subjects

We evaluate the influence of the thirteen variants on susceptibility to colorectal cancer with 247 cases and 300 controls in Chinese Northwest Population. All the cases were treated at the First Affiliated Hospital of Xi’an Jiaotong University between June 2013 and May 2016. According to the guidance statement described by Qaseem A et al [32], the diagnosis criteria of CRC contain clinical history, routine laboratory evaluation and histopathological detection, and all the cases were patients with positive colonoscopic results for malignancy. The inclusion criteria of the cases also contained the expected survival of more than three months, and qualified hematology, liver and kidney function. In addition, the controls included individuals undergoing colonoscopy for various gastrointestinal complaints and sampled at the same time as the cases. The controls were negative colonoscopic results for malignancy and never had any type of disease, including cardiovascular diseases, hepatic disease and pulmonary diseases. All subjects were interviewed by a nurse who collected detailed information about gender, age, region and ethnicity.

Ethics committee statement

The use of human tissue and the protocol in this study were strictly conformed in accordance with the tenets of the Declaration of Helsinki and were approved by the Ethical the First Affiliated Hospital of Xi’an Jiaotong University and Xi’an Jiaotong University for approval of research involving human subjects. The individual in this manuscript has given written informed consent to publish these case details.

SNP selection and genotyping

In this case-control study, we selected 4 SNPs in TERT (rs10069690, rs2242652, rs2853677, rs2853676), 3 SNPs in TNIP1 (rs3792792, rs7708392, rs10036748) and 4 SNPs in OBFC1 (rs3814220, rs12765878, rs11191865, rs9420907), each with a minor allele frequency (MAF) higher than 5% in the Han Chinese population. Genomic DNA extracted from whole blood by GoldMag extraction method (GoldMag Co. Ltd, Xi’an, China) [33], and then DNA was stored at −80°C. Spectrometry (DU530UV/VIS spectrophotometer, Beckman Instruments, Fullerton, CA, USA) was used to measure the DNA concentration. According to the manufacturer's protocols, Sequenom MassARRAY® RS1000 system (Agena Bioscience Inc., San Diego, CA, USA) was used to perform genotyping, and the Sequence MassARRAY Assay Design 4.0 (Agena Bioscience Inc.) software was used to design a Multiplexed SNP mass-EXTEND assay [34]. After genotyping, Sequenom Typer 4.0 Software (Agena Bioscience Inc.) was used to conduct data analysis [35].

Statistical analysis

SPSS 17.0 statistical packages (SPSS, Chicago, IL) were used to perform the differences of subjects’ characteristic containing gender and age. All P values were two-sided, and values of P≤0.05 were considered significant. The genotype frequency distribution of each SNP needs accord with Hardy-Weinberg Equilibrium (HWE) in controls, and exact test was used to check the feature. The alleles and genotype frequencies among cases and controls were calculated by Chi-squared test or Continuity Correction test. Odds ratios (OR) and 95% Confidence Intervals (CI) were used to evaluate the association between genotypes and CRC risk in four models (genotype, dominant, recessive and additive model) using unconditional logistic analysis adjusted for age and gender. In order to eliminate the probability of false-positive results, Bonferroni's multiple adjustment was applied to the level of significance, which was set at P < 0.0011 (0.05/44). Finally, SHEsis software platform [36] and Haploview software package (version 4.2) (Broad Institute, Cambridge, MA, USA) was used to perform the linkage disequilibrium (LD), and to analysis the association at polymorphic loci [37]. The D ≥ 0.8 indicated that a pair of SNPs had a significant LD, and tended to co-inheritance.

ACKNOWLEDGMENTS AND FUNDING

This work did not have any funding support.

Abbreviations

CRC
colorectal cancer
SNP
single nucleotide polymorphism
OR
odds ratio
CI
confidence interval
LD
linkage disequilibrium

Footnotes

CONFLICTS OF INTEREST

The authors have declared that they have no conflicts of interest.

Contributed by

Author contributions

Xinhan Zhao and Zixuan Zhao not only conceived and designed the experiments, but also contributed reagents/materials/analysis tools.

Chuang Li and Jun Zhou wrote the manuscript.

Ying Liu and Hao Wang performed the experiments.

REFERENCES

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E86. doi: 10.1002/ijc.29210. [PubMed] [Cross Ref]
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:225–49. doi: 10.3322/CA.2007.0010. [PubMed] [Cross Ref]
3. Grady WM. Genomic instability and colon cancer. Cancer Metastasis Rev. 2004;23:11–27. doi: 10.1023/A:1025861527711. [PubMed] [Cross Ref]
4. Bertorelle R, Rampazzo E, Pucciarelli S, Nitti D, De RA. Telomeres, telomerase and colorectal cancer. World J Gastroenterol. 2014;20:1940–1950. doi: 10.3748/wjg.v20.i8.1940. [PMC free article] [PubMed] [Cross Ref]
5. Wentzensen IM, Mirabello L, Pfeiffer RM, Savage SA. The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2011;20:1238–1250. doi: 10.1158/1055-9965. [PMC free article] [PubMed] [Cross Ref]
6. Codd V, Nelson CP, Albrecht E, Mangino M, Deelen J, Buxton JL, Hottenga JJ, Fischer K, Esko T, Surakka I, Broer L, Nyholt DR, Mateo Leach I, et al. Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet. 2013;45:422–427. doi: 10.1038/ng.2528. [PMC free article] [PubMed] [Cross Ref]
7. Levy D, Neuhausen SL, Hunt SC, Kimura M, Hwang SJ, Chen W, Bis JC, Fitzpatrick AL, Smith E, Johnson AD, Gardner JP, Srinivasan SR, Schork N, et al. Genome-wide association identifies OBFC1 as a locus involved in human leukocyte telomere biology. Proc Natl Acad Sci USA. 2010;107:9293–9298. doi: 10.1073/pnas.0911494107. [PubMed] [Cross Ref]
8. Pellatt AJ, Wolff RK, Torres-Mejia G, John EM, Herrick JS, Lundgreen A, Baumgartner KB, Giuliano AR, Hines LM, Fejerman L, Cawthon R, Slattery ML. Telomere length, telomere-related genes, and breast cancer risk: the breast cancer health disparities study. Gene Chromosomes Cancer. 2013;52:595–609. doi: 10.1002/gcc.22056. [PMC free article] [PubMed] [Cross Ref]
9. Nan H, Qureshi AA, Prescott J, Vivo ID, Han J. Genetic variants in telomere-maintaining genes and skin cancer risk. Hum Genet. 2011;129:247–253. doi: 10.1007/s00439-010-0921-5. [PMC free article] [PubMed] [Cross Ref]
10. Nassiri M, Kooshyar MM, Roudbar Z, Mahdavi M, Doosti M. Genes and SNPs associated with non-hereditary and hereditary colorectal cancer. Asian Pac J Cancer Prev. 2013;14:5609–5614. doi: 10.7314/APJCP.2013.14.10.5609. [PubMed] [Cross Ref]
11. Yao K, Hua L, Wei L, Meng J, Hu J. Correlation between CASC8, SMAD7 polymorphisms and the susceptibility to colorectal cancer: an updated meta-analysis based on GWAS results. Medicine (Baltimore) 2015;94:e1884. doi: 10.1097/MD.0000000000001884. [PMC free article] [PubMed] [Cross Ref]
12. Kraus S, Nabiochtchikov I, Shapira S, Arber N. Recent advances in personalized colorectal cancer research. Cancer Lett. 2014;347:15–21. doi: 10.1016/j.canlet.2014.01.025. [PubMed] [Cross Ref]
13. Fernández-Marcelo T, Sánchez-Pernaute A, Pascua I, De JC, Head J, Torres-García AJ, Iniesta P. Clinical relevance of telomere status and telomerase activity in colorectal cancer. PLoS One. 2016;11:e0149626. doi: 10.1371/journal.pone.0149626. [PMC free article] [PubMed] [Cross Ref]
14. Gurevich I, Zhang C, Francis N, Aneskievich BJ. TNIP1, a retinoic acid receptor corepressor and A20-binding inhibitor of NF-κB, distributes to both nuclear and cytoplasmic locations. J Histochem Cytochem. 2011;59:1101–1112. doi: 10.1369/0022155411427728. [PubMed] [Cross Ref]
15. Nagaraju GP, Zafar SF, El-Rayes BF. Pleiotropic effects of genistein in metabolic, inflammatory, and malignant diseases. Nutr Rev. 2013;71:562–572. doi: 10.1111/nure.12044. [PubMed] [Cross Ref]
16. Zubair A, Frieri M. Role of nuclear factor-ĸB in breast and colorectal cancer. Curr Allergy Asthma Rep. 2013;13:44–49. doi: 10.1007/s11882-012-0300-5. [PubMed] [Cross Ref]
17. Rezapour S, Bahrami T, Hashemzadeh S, Estiar MA, Nemati M, Ravanbakhsh R, Feizi MA, Kafil HS, Pouladi N, Ghojazadeh M. STC1 and NF-κB p65 (Rel A) is constitutively activated in colorectal cancer. Clin Lab. 2016;62:463–469. doi: 10.7754/Clin.Lab.2015.150827. [PubMed] [Cross Ref]
18. Weng W, Feng J, Qin H, Ma Y. Molecular therapy of colorectal cancer: progress and future directions. Int J Cancer. 2015;136:493–502. doi: 10.1002/ijc.28722. [PubMed] [Cross Ref]
19. Rajitha B, Belalcazar A, Nagaraju GP, Shaib WL, Snyder JP, Shoji M, Pattnaik S, Alam A, El-Rayes BF. Inhibition of NF-κB translocation by curcumin analogs induces G0/G1 arrest and downregulates thymidylate synthase in colorectal cancer. Cancer Lett. 2016;373:227–233. doi: 10.1016/j.canlet.2016.01.052. [PubMed] [Cross Ref]
20. Pelicci PG, Dalton P, Giorgio M. The other face of ROS: a driver of stem cell expansion in colorectal cancer. Cell Stem Cell. 2013;12:635–636. doi: 10.1016/j.stem.2013.05.023. [PubMed] [Cross Ref]
21. Vaiopoulos AG, Athanasoula KC, Papavassiliou AG. NF-κB in colorectal cancer. J Mol Med. 2013;91:1029–1037. doi: 10.1007/s00109-013-1045-x. [PubMed] [Cross Ref]
22. Song S, Chen D, Lu J, Liao J, Luo Y, Yang Z, Fu X, Fan X, Wei Y, Yang L, Wang L, Wang J. NFκB1 and NFκBIA polymorphisms are associated with increased risk for sporadic colorectal cancer in a southern Chinese population. PLoS One. 2011;6:e21726. doi: 10.1371/journal.pone.0021726. [PMC free article] [PubMed] [Cross Ref]
23. Lewander A. Polymorphism and expression of NF-κB in relation to susceptibility and prognosis of colorectal cancer patients. Linköping University Electronic Press; 2010.
24. Kawasaki A, Ito S, Furukawa H, Hayashi T, Goto D, Matsumoto I, Kusaoi M, Ohashi J, Graham RR, Matsuta K, Behrens TW, Tohma S, Takasaki Y, et al. Association of TNFAIP3 interacting protein 1, TNIP1 with systemic lupus erythematosus in a Japanese population: a case-control association study. Arthritis Res Ther. 2010;12:R174. doi: 10.1186/ar3134. [PMC free article] [PubMed] [Cross Ref]
25. Zhang DM, Cheng LQ, Zhai ZF, Feng L, Zhong BY, You Y, Zhang N, Song ZQ, Yang XC, Chen FR, Hao F. Single-nucleotide polymorphism and haplotypes of TNIP1 associated with systemic lupus erythematosus in a Chinese Han population. J Rheumatol. 2013;40:1535–1544. doi: 10.3899/jrheum.121391. [PubMed] [Cross Ref]
26. Han JW, Zheng HF, Cui Y, Sun LD, Ye DQ, Hu Z, Xu JH, Cai ZM, Huang W, Zhao GP, Xie HF, Fang H, Lu QJ, et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet. 2009;41:1234–1237. doi: 10.3899/jrheum.121391. [PubMed] [Cross Ref]
27. Li X1, Ampleford EJ, Howard TD, Moore WC, Torgerson DG, Li H, Busse WW, Castro M, Erzurum SC, Israel E, Nicolae DL, Ober C, Wenzel SE, et al. Genome-wide association studies of asthma indicate opposite immunopathogenesis direction from autoimmune diseases. J Allergy Clin Immunol. 2012;130 doi: 10.1016/j.jaci.2012.04.041. 861-8.e7. [PMC free article] [PubMed] [Cross Ref]
28. Hofer P, Baierl A, Bernhart K, Leeb G, Mach K, Micksche M, Gsur A. Association of genetic variants of human telomerase with colorectal polyps and colorectal cancer risk † Mol Carcinog. 2012;1:176–182. doi: 10.1002/mc.21911. [PubMed] [Cross Ref]
29. Cao JL, Yuan P, Abuduwufuer A, Lv W, Yang YH, Hu J. Association between the TERT genetic polymorphism rs2853676 and cancer risk: meta-analysis of 76 108 cases and 134 215 controls. PLoS One. 2014;10:e0128829. doi: 10.1371/journal.pone.0128829. [PMC free article] [PubMed] [Cross Ref]
30. Pellatt AJ, Wolff RK, Herrick J, Lundgreen A, Slattery ML. TERT's role in colorectal carcinogenesis. Mol Carcinog. 2013;52:507–513. doi: 10.1002/mc.21885. [PMC free article] [PubMed] [Cross Ref]
31. Wu M, Assassi S, Salazar GA, Pedroza C, Gorlova OY, Chen WV, Charles J, Taing ML, Liao K, Wigley FM, Hummers LK, Shah AA, Hinchcliff M, et al. Genetic susceptibility loci of idiopathic interstitial pneumonia do not represent risk for systemic sclerosis: a case control study in Caucasian patients. Arthritis Res Ther. 2016;18:20–30. doi: 10.1186/s13075-016-0923-3. [PMC free article] [PubMed] [Cross Ref]
32. Qaseem A, Denberg TD, Hopkins RH, Humphrey LL, Levine J, Sweet DE, Shekelle P. Screening for colorectal cancer: a guidance statement from the American College of Physicians. Ann Intern Med. 2012;156:378–386. doi: 10.7326/0003-4819-156-5-201203060-00010. [PubMed] [Cross Ref]
33. Köchl S, Niederstätter H, Parson W. DNA extraction and quantitation of forensic samples using the phenol-chloroform method and real-time PCR. Methods Mol Biol. 2005;297:13–29. doi: 10.1385/1-59259-867-6:013. [PubMed] [Cross Ref]
34. Trembizki E, Smith H, Lahra MM, Chen M, Donovan B, Fairley CK, Guy R, Kaldor J, Regan D, Ward J, Nissen MD, Sloots TP, Whiley DM. High-throughput informative single nucleotide polymorphism-based typing of Neisseria gonorrhoeae using the Sequenom MassARRAY iPLEX platform. J Antimicrob Chemother. 2014;69:1526–1532. doi: 10.1093/jac/dkt544. [PubMed] [Cross Ref]
35. Thomas RK, Baker AC, Debiasi RM, Winckler W, Laframboise T, Lin WM, Wang M, Feng W, Zander T, MacConaill L, Lee JC, Nicoletti R, Hatton C, et al. High-throughput oncogene mutation profiling in human cancer. Nat Genet. 2007;39:347–351. doi: 10.1038/ng1975. [PubMed] [Cross Ref]
36. Li Z, Zhang Z, He Z, Ting W, Li T, Zeng Z, He L, Shi Y. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis. Cell Res. 2009;19:519–523. doi: 10.1038/cr.2009.33. http://analysis.bio-x.cn. [PubMed] [Cross Ref]
37. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–265. doi: 10.1093/bioinformatics/bth457. [PubMed] [Cross Ref]

Articles from Oncotarget are provided here courtesy of Impact Journals, LLC